(19)
(11) EP 4 486 889 A1

(12)

(43) Date of publication:
08.01.2025 Bulletin 2025/02

(21) Application number: 23708802.6

(22) Date of filing: 06.03.2023
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61K 31/7088(2006.01)
G01N 33/574(2006.01)
C12N 9/02(2006.01)
C12Q 1/26(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/1137; C12N 9/0051; C12Y 108/03005; A61K 31/7088; C12N 2310/20; C12N 2310/14; G01N 33/5011; G01N 33/5038; G01N 2800/52
 
C-Sets:
C12N 2310/14, C12N 2310/531;
(86) International application number:
PCT/EP2023/055604
(87) International publication number:
WO 2023/166226 (07.09.2023 Gazette 2023/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 04.03.2022 IT 202200004193

(71) Applicants:
  • Istituto Europeo di Oncologia S.r.l.
    20121 Milano (MI) (IT)
  • Centro Cardiologico Monzino S.p.A.
    20121 Milano (IT)
  • Università degli Studi di Milano
    20122 Milano (IT)

(72) Inventors:
  • BANFI, Cristina
    20121 Milano (MI) (IT)
  • MINUCCI, Saverio
    20121 Milano (MI) (IT)
  • PALLAVICINI, Isabella
    20121 Milano (MI) (IT)

(74) Representative: Currado, Luisa et al
De Simone & Partners S.r.l. Via Giulio Caccini, 1
00198 Roma
00198 Roma (IT)

   


(54) THERAPEUTIC USES OF PCYOX1 INHIBITORS